February is the shortest month, but there was still plenty of time for a rush of pharma and biotech hires, including a number of changes at the big pharmas, which may have slipped under your radar, ...

In today’s interconnected global economy, geopolitical shocks cascade through trade, production, and financial networks that were built for efficiency, not resilience. As disruptions hit critical ...

For The HEINEKEN Company’s APAC insights lead, growth today depends on navigating volatility without losing brand integrity. Sebnem Uner Sahbaz has spent 20 years navigating complexity. From Istanbul ...

The United States’ unique economic advantages – deep financial markets, a strong institutional framework, and the world's dominant reserve currency – should not be mistaken for invincibility. In fact, ...

Novo Nordisk’s Wegovy (semaglutide injection) has received a new approval from the Medicines and Healthcare products Regulatory Agency (MHRA), this time for a 7.2mg dose designed for the weight ...

Şebnem Hassanisoughi was born in Istanbul. Her father is of Azerbaijani descent from Iran. Her mother is Turkish. Sebnem took on roles in some very significant shows such as, 'Firar', 'Kayip Sehir', ...

Poverty, migration and household livelihoods specialist with extensive experience of using quantitative and qualitative approaches to data collection and analysis. I am the Head of the Centre for the ...

A number of people are interested in contacting Sebnem Ferah's management and agent for potential commercial opportunities and business-to-business engagements. Let The Handbook help you to contact ...

Pharma giants eye Britain as a global guinea pig for new treatments Hannah Boland is The Telegraph’s Retail Editor. She has broken numerous stories on Asda's turnaround efforts, M&S's cyber attack and ...

Telomeres — the “caps” on the end of chromosomes that protect the DNA from damage — have been associated with greater longevity. In theory, longer telomeres should allow a cell to divide more times ...

Novo Nordisk has been accepted back into the fold. Two years after suspending Novo, the Association of the British Pharmaceutical Industry (ABPI) has reinstated the Danish drugmaker after seeing ...